STOCK TITAN

Phathom Pharmaceuticals, Inc. (PHAT) Net Income by Year

PHAT

Phathom Pharmaceuticals, Inc. reported a net loss of $221K in fiscal year 2025. This represents an increase of 33.8% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $122.0M in net income. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Phathom Pharmaceuticals, Inc. has filed alongside them.

FY2025 annual
Net Income -$221K
YoY +33.8%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

PHAT Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-K
Net Income$122.0M-$221K+33.8%-$334K-65.8%-$202K+99.9%-$197.7M-37.4%-$143.9M-11.5%-$129.1M+49.4%-$255.1M-19708.3%-$1.3M

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

PHAT Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$17.6M+76.8%-$30.4M+67.8%$199.9M-23.0%-$30.0M+65.0%-$75.8M+17.1%-$94.3M-13.8%$259.5M-$85.6M-97.9%-$91.4M-123.2%-$82.9M-119.1%N/A-$43.2M+15.4%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Phathom Pharmaceuticals, Inc. financials

Frequently Asked Questions

What was Phathom Pharmaceuticals, Inc.'s net income in fiscal year 2025?

Phathom Pharmaceuticals, Inc. reported a net loss of $221K in fiscal year 2025.

How fast is Phathom Pharmaceuticals, Inc.'s net income growing?

Phathom Pharmaceuticals, Inc. (PHAT) net income rose by 33.8% year over year, from -$334K to -$221K in fiscal year 2025.

What is Phathom Pharmaceuticals, Inc.'s net income over the last twelve months?

Phathom Pharmaceuticals, Inc. (PHAT) reported $122.0M in net income over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 8 fiscal years this page covers, Phathom Pharmaceuticals, Inc. (PHAT) net income went from -$1.3M in fiscal year 2018 to -$221K in fiscal year 2025.

Phathom Pharmaceuticals, Inc. (PHAT) reported -$17.6M in net income in Q2 2026. This represents an increase of 76.8% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Phathom Pharmaceuticals, Inc. (PHAT) reported on that line in every period on record.